首页> 美国卫生研究院文献>Molecular Imaging and Radionuclide Therapy >Detection of Sentinel Lymph Nodes in Gynecologic Tumours by Planar Scintigraphy and SPECT/CT
【2h】

Detection of Sentinel Lymph Nodes in Gynecologic Tumours by Planar Scintigraphy and SPECT/CT

机译:平面闪烁扫描和SPECT / CT技术检测妇科肿瘤前哨淋巴结

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Objective: Assess the role of planar lymphoscintigraphy and fusion imaging of SPECT/CT in sentinel lymph node (SLN) detection in patients with gynecologic tumours.>Material and Methods: Planar scintigraphy and hybrid modality SPECT/CT were performed in 64 consecutive women with gynecologic tumours (mean age 53.6 with range 30-77 years): 36 pts with cervical cancer (Group A), 21 pts with endometrial cancer (Group B), 7 pts with vulvar carcinoma (Group C). Planar and SPECT/CT images were interpreted separately by two nuclear medicine physicians. Efficacy of these two techniques to image SLN were compared.>Results: Planar scintigraphy did not image SLN in 7 patients (10.9%), SPECT/CT was negative in 4 patients (6.3%). In 35 (54.7%) patients the number of SLNs captured on SPECT/CT was higher than on planar imaging. Differences in detection of SLN between planar and SPECT/CT imaging in the group of all 64 patients are statistically significant (p<0.05). Three foci of uptake (1.7% from totally visible 177 foci on planar images) in 2 patients interpreted on planar images as hot LNs were found to be false positive non-nodal sites of uptake when further assessed on SPECT/CT. SPECT/CT showed the exact anatomical location of all visualised sentinel nodes. >Conclusion: In some patients with gynecologic cancers SPECT/CT improves detection of sentinel lymph nodes. It can image nodes not visible on planar scintigrams, exclude false positive uptake and exactly localise pelvic and paraaortal SLNs. It improves anatomic localization of SLNs. >Conflict of interest:None declared.
机译:>目的:评估平面淋巴闪烁显像和SPECT / CT融合成像在妇科肿瘤患者前哨淋巴结(SLN)检测中的作用。>材料与方法:混合模式SPECT / CT在64例连续的妇科肿瘤女性(平均年龄53.6,范围30-77岁)中进行:宫颈癌36例(A组),子宫内膜癌21例(B组),外阴癌7例癌(C组)。两名核医学医师分别解释了平面和SPECT / CT图像。比较了这两种技术对SLN成像的功效。>结果: 7例(10.9%)的平面闪烁扫描未对SLN成像,4例(6.3%)的SPECT / CT阴性。在35名(54.7%)患者中,SPECT / CT捕获的SLN数量高于平面成像。在所有64例患者中,平面和SPECT / CT成像之间SLN的检测差异具有统计学意义(p <0.05)。在SPECT / CT上进一步评估时,在2例在平面图像上被解释为热LN的患者中,有3个摄取焦点(占平面图像上的全部177个焦点的1.7%)被发现是假阳性的非结点摄取部位。 SPECT / CT显示所有可视化前哨淋巴结的确切解剖位置。 >结论:在某些妇科癌症患者中,SPECT / CT可改善前哨淋巴结的检测。它可以对平面闪烁图上不可见的节点成像,排除假阳性摄取,并精确定位骨盆和腹主动脉旁淋巴结。它改善了SLN的解剖定位。 >利益冲突:未声明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号